Patent · US Active

Pharmaceutical combinations comprising a thionucleotide analog

US9012427B2 · kind B2 · utility

31Cited by

159References

41Claims

0Family size

Assignee

ALIOS BIOPHARMA, INC. · US

Inventors

Lawrence M. Blatt · San Francisco, US
Leonid Beigelman · San Mateo, US
Hua Tan · Daly City, US
Julian Alexander Symons · Redwood City, US
David Bernard Smith · San Mateo, US
Min Jiang · Beijing, CN
Tara Lynn Kieffer · Brookline, US
Cornelis A. RIJNBRAND · Poway, US

Key dates

Filing date	Mar 12, 2013
Grant date	Apr 21, 2015
Priority date	—
Expiry date	Apr 10, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are pharmaceutical compositions that can include a thionucleotide analog for use in combination therapy with other agents. Also disclosed herein are methods of treating diseases and/or conditions with a pharmaceutical composition that can include a thionucleotide analog in combination therapy with other agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.